Pacific Biosciences of California | 8-K: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Schedul
Pacific Biosciences of California | 8-K: PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Schedul
Pacific Biosciences of California | 8-K:PacBio 公布 2024 年第一季度初步收入和更新 2024 年收入指引宣布计划将 2024 年第一季度年化运营费用运行率降低 5,000 万至 7,500 万美元的 2024 年第一季度财报电话会议定于 2024 年 5 月 9 日举行